Derivatives of [2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic Acid and Methods of Making Them
申请人:Baudy Bernhard Reinhardt
公开号:US20070244100A1
公开(公告)日:2007-10-18
Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided:
wherein: A is alkylenyl of 1 to 4 carbon atoms, or alkenylenyl of 2 to 4 carbon atoms;
R
1
and R
2
are, independently, hydrogen or a C
5
to C
7
aryl optionally substituted with 1 to 2 substituents, independently, selected from the group consisting of —C(O)R
3
, halogen, cyano, nitro, hydroxyl, C
1
-C
6
alkyl, and C
1
-C
6
alkoxy,
with the proviso that at least one of R
1
and R
2
is not hydrogen;
R
3
is, independently, hydrogen, —OR
4
, alkyl, aryl, or heteroaryl;
R
4
is hydrogen, alkyl, aryl, or heteroaryl;
R
5
and R
6
are, independently, hydrogen, alkyl, hydroxyl, alkoxy, or C
5
to C
7
aryl;
wherein any R
3
to R
6
group having an aryl or heteroaryl moiety can optionally be substituted on the aryl or heteroaryl moiety with 1 to about 5 substituents, independently, selected from the group consisting of halogen, cyano, nitro, hydroxyl, C
1
-C
6
alkyl, and C
1
-C
6
alkoxy. Methods of making these compounds as well as methods using the compounds for treating a variety of conditions are also disclosed.
提供化学式(I)的化合物或其药学上可接受的盐:
其中:A是1至4个碳原子的烷基或2至4个碳原子的烯基烷基;
R1和R2独立地为氢或C5到C7芳基,可选地取代1至2个取代基,独立地从羟基,卤素,氰基,硝基,羟基,C1-C6烷基和C1-C6烷氧基的组中选择,
但至少一个R1和R2不是氢;
R3独立地为氢,OR4,烷基,芳基或杂环芳基;
R4为氢,烷基,芳基或杂环芳基;
R5和R6独立地为氢,烷基,羟基,烷氧基或C5至C7芳基;
其中,任何具有芳基或杂环芳基基团的R3至R6基团可以选择地在芳基或杂环芳基基团上取代1至约5个取代基,独立地从卤素,氰基,硝基,羟基,C1-C6烷基和C1-C6烷氧基的组中选择。
还公开了制备这些化合物的方法以及使用这些化合物治疗各种疾病的方法。